Successful re-exposition of clozapine after drug fever;Reexposition mit clozapin nach arzneimittelfieber: Ein UAW-fall aus der datenbank der AGATE

Psychopharmakotherapie

Volumn 16, Issue 6, 2009, Pages 253-255

  Wittmann, Markus ^a   Dachl, Jürgen ^a   Berges, Natalie ^a   Hajak, Göran ^a   Haen, Ekkehard ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Clozapine; CRP elevation; Drug fever

Indexed keywords

C REACTIVE PROTEIN; CLOZAPINE;

ADULT; CASE REPORT; DRUG EFFECT; DRUG EXPOSURE; DRUG FEVER; HUMAN; MALE; NOTE; RETREATMENT; SCHIZOPHRENIA;

EID: 71749094966     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (6)

1. Agelink MW, Kornischka J, Cordes J, Klimke A, et al. Allgemeinmedizinische Aspekte der Therapie mit Antipsychotika der zweiten Generation. Dtsch Arztebl 2006;103:2802-2808
2. Haack M-J, Bak MLFJ, Beurskens R, Maes M, et al. Toxic rise of clozapine plasma concentrations in relation to inflammation. Eur Neuropsychopharmacol 2003;13:381-385 (Pubitemid 37040921)
3. Lowe CM, Grube RR, Scates AC. Characterization and clinical management of clozapine-induced fever. Ann Pharmacother 2007;41:1700-1704
4. Mueller H, Hammes E, Hiemke C, Benkert O. Influence of clozapine on body temperature and on acute phase proteins. Pharmacopsychiatry 1992;25:109.
5. Naber D, Lamert M, Krausz M, Haasen C. Atypische Neuroleptika in der Behandlung schizophrener Patienten. Bremen: UNI-MED-Verlag, 2000:124.
6. Tham JC, Dickson RA. Clozapin-induced fevers and 1-years clozapine discontinuation rate. J Clin Psychiatry 2002;63:880-884